September 20, 2016 06:42 AM EDTUpdated 11:04 AM
People
Bioregnum
Opinion

GSK makes a lit­tle his­to­ry while out­lin­ing a fa­mil­iar fu­ture

Glax­o­SmithK­line made phar­ma his­to­ry to­day by ap­point­ing Em­ma Walm­s­ley as the first woman to run a glob­al drug mak­er. And she will have to …

Endpoints Premium

This article is available only to Premium subscribers

Upgrade to Premium for unlimited access and Premium exclusives.

UPGRADE
TRENDING NOW

PTC re­ports Phase 2 ALS fail, sells pri­or­i­ty re­view vouch­er for $150M

No­var­tis to cut 139 jobs in NJ as part of com­mer­cial re­fo­cus

Ap­plied Ther­a­peu­tic­s' rare dis­ease drug gets a CRL

To lead NIH, Trump taps Stan­ford aca­d­e­m­ic and pan­dem­ic re­sponse crit­ic Jay Bhat­tacharya

FDA is look­ing in­to hema­tol­ogy risks af­ter pa­tients take Blue­bird's Skysona gene ther­a­py

Bris­tol My­ers sues the fed­er­al gov­ern­ment over 340B, fol­low­ing oth­er drug­mak­ers

A service from the Financial Times